The Regenerative Medicine Standards Landscape

LandscapeReportCover.png

In 2018, Nexight Group LLC and SCB co-authored The Regenerative Medicine Standards Landscape report with funding from the U.S. Food and Drug Administration (FDA). This report provides a snapshot of the current landscape for regenerative medicine standards. It outlines existing and in-development standards, providing a reference that individual organizations can use to identify available standards to improve their operations.

The first iteration of this report was developed in an accelerated 3-month timeframe and published in December 2017, with updates in February 2018 and in this Spring 2019 edition. Given the constantly-evolving nature of the field of regenerative medicine, SCB will continue to engage stakeholders to build on and refine this document in support of its mission.

If you have suggestions for improving this report, please send your feedback to Sarah Lichtner (slichtner@nexightgroup.com).